Posted by xjs7 on March 14, 2003, at 21:28:09
In reply to molecular modeling and TD risk of newer atypicals, posted by zeugma on March 14, 2003, at 20:42:50
Hi Zeugma,
Thanks for posting that link--it is very interesting. I take one of the drugs that have a higher incidence of EPS (Geodon) and, sure enough, I get moderate EPS from it. Fortunately, we have Cogentin and related drugs for this problem.
I think that TD is more worrisome than EPS--it can be irreversable, whereas EPS is usually just uncomfortable. If Abilify does not cause TD, then I would expect that doctors will move all their patients to it. Abilify is also great in that it does not cause massive weight gain like clozapine.
xjs7
poster:xjs7
thread:208427
URL: http://www.dr-bob.org/babble/20030314/msgs/209210.html